Why the Althea (ASX:AGH) share price will be on watch today

The Althea Group Holdings Ltd (ASX: AGH) share price will be on watch this morning. This comes after the company announced that it signed a new supply and distribution agreement.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price will be on watch this morning. This comes after the company announced that it signed a supply and distribution agreement with a UK medical cannabis supplier.

At yesterday's close of market, the Althea share price finished the day at 43 cents.

little green pharma share price represented by cannabis leaf character jumping cheerfully

Image source: Getty Images

New agreement

Althea advised it has entered a contract with medicinal cannabis supplier Lyphe Group to supply and distribute its products in the United Kingdom, and the nearby island Jersey.

Under the terms, Althea will supply Lyphe with its medicinal cannabis products for non-exclusive distribution rights across the United Kingdom. Patients will have access to the products through The Medical Cannabis Clinics (TMCC). This will be dispensed through Lyphe's own pharmacy, Dispensary Green.

In Jersey, TMCC recently opened up, thus allowing Lyphe to establish a new distribution structure. Althea will grant Lyphe exclusive distribution rights for Jersey, where it seeks to support thousands of medicinal cannabis patients.

Subject to customary conditions, the deal is set for an initial 12 months, with the option to extend further.

What did both parties say?

Althea CEO Mr Josh Fegan commented on the new partnership:

The supply and distribution agreement with Lyphe Group is an important milestone in Althea's UK strategy, as the Company continues to increase its market share in the rapidly growing territory. The agreement with Lyphe Group creates supplementary growth for the Company, whilst further enhancing our brand awareness and standing in the marketplace. We look forward to the Althea brand continuing to have strong representation on Lyphe Group's formulary in the UK and Jersey.

Lyphe Group CEO, Mr Dean Friday added to Mr Fegan's comments:

It's hard to believe that a few months ago none of the patients in Jersey were able to obtain critical medical cannabis treatments, instead they were driven to the black market. Now, not only does LYPHE Group have an operating clinic on the island, TMCC Jersey, it also has a fantastic pharmacy partner in Reid's Pharmacy chain. We are pleased that Althea has come onboard with us as we work to ensure every patient has a consistent and affordable supply of medical cannabis.

About the Althea share price

The Althea share price has performed well over the past 12 months, rising by 22%.

The company's shares reached a multi-year low of 15 cents in March, and a 52-week high of 67 cents in September.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »